Order
Information
SUMMARY
Enteric fever occurs when pathogenic microorganisms like S. typhi,
S. parathypi A, S. parathypi B infect the human body. During the
course of disease, the body responds to this antigenic stimulation
by producing antibodies whose titre rises slowly in early stages,
to a maxima and than slowly falls till it is undetectable. However
in endemic areas, antibody titres upto 1:60 may be detectable in
normal population. Antibodies to Salmonella organism may be detected
in the patient serum from the second week after on set of infection.
Information regarding the titres and whether or not they are rising
or falling can be obtained by performing serological tests using
WIDAL antigen suspension.
REAGENT
TYDAL contains ready to use concentrated, colour coded, smooth
antigen suspensions of the bacilli; S. typhi O, S. typhi H, S. parathypi
AH, S. parathypi BH, along with a polyspecific positive control
reactive with these antigens. Each batch of reagents undergoes rigorous
quality control at various stages of manufacture for its specificity
and performance.
REAGENT STORAGE AND STABILITY
a) Store the reagent at 2-8°C. DO NOT FREEZE
b) The shelf life of the reagents is as per the expiry date mentioned
on the
PRINCIPLE
When the coloured, smooth attenuated WIDAL antigen suspensions
are mixed/incubated with patient serum, anti-salmonella antibodies
present in the patient serum react with the antigen suspensions
to give an agglutination. Agglutination is a positive test result,
indicating he presence of anti-salmonella antibodies in the patient
sample. No agglutination is a negative test result indicating absence
of anti-salmonella antibodies.
NOTE :
In Vitro diagnostics reagent for laboratory and professional use
only. Not for medicine use. The reagent contain 0.5% Phenol / 0.3%
Formaldehyde as preservative. Avoid contact with skin and mucosa.
On disposal flush with large quantities of water. Extreme turbidity
may indicate microbial contamination / reagent deterioration. Such
reagents should be discarded.
SAMPLES COLLECTION AND STORAGE
1. No special preparation of the patient is required prior to
sample collection by approved techniques. Do not use haemolysed
samples.
2. Clean and dry glassware free from detergents must be used for
sample collection.
3. Do not heat inactivate the serum.
4. Though freshly collected serum is preferable, store samples at
2-8°C in case of delay in testing.
MATERIAL PROVIDED WITH THE KIT
a) Reagent Pack
Antigen suspension S. typhi 'O'
Antigen suspension S. typhi 'H'
Antigen suspension S. parathyphi 'AH'
Antigen suspension S. parathyphi 'BH'
Polyspecific positive control (Goat)
Accessories Pack
Glass slide with 6 reaction circles
Mixing sticks
Disposable sample dispensing pipettes with rubber teats
ADDITIONAL MATERIAL REQUIRED
Slide Test Method : Stop Watch
Quantitative Method : Timer, Kahn Tubes, Test Tubes, Pipettes (0.1
ml, 1ml) Isotonic saline, Incubator (37°C), Test Tube rack.
|
PROCEDURE :
a) Bring all reagents to room temperature before testing.
b) Shake and mix antigens well before dispensing.
SLIDE TEST METHOD
1. Place one drop of positive control onto the reaction circle
(PC) of the glass slide with the disposable droppers provided with
the kit.
2. Place one drop o isotonic saline onto the next reaction circle
(NC) of the glass slide.
3. Place one drop of patient serum to be tested onto the remaining
four reaction circles.
4. Add one drop of WIDAL antigen suspension 'H' to the first
two reaction circles (PN, NC)
5. Add one drop of WIDAL antigen suspensions 'O','H', 'AH',
'BH' to the corresponding reaction circle. with separate mixing
sticks.
6. Mix contents of each circle uniformly over the entire circle
with separate mixing sticks.
7. Rock the slide gently, back and forth, and observe for agglutination
macroscopically at one minute.
QUANTITATIVE METHOD
TUBE TEST PROCEDURE
1. Take 4 sets of 8 Kahn tubes/test tubes and label them
1 to 8 for O, H, AH and BH, antibody detection.
2. Pipette into the tube no. 1 of all sets1.9 ml of isotonic
saline.
3. To each of the remaining (2 to 8) add 1.0 ml of isotonic
saline.
4. To tube no. 1 of all the sets add 0.1ml of serum sample to
be tested and mix well.
5. Transfer 1.0 ml of the diluted sample from tube no. 1 to
tube no. 2 and mix well.
6. Transfer 1.0 ml of the diluted sample from tube no. 2
to tube no. 3 and mix well. Continue this serial dilution till tube
no.7 in each set.
7. Discard 1.0 ml of the diluted serum from tube no. 7 of
each set.
8. Tube no 8 in all sets, serves as saline control. Now the
dilution of the serum samples achieved in each set is as follows.
| Tube no |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8(Control) |
| Dilution |
1:20 |
1:40 |
1:80 |
1:60 |
1:630 |
1:640 |
1:1280 |
|
9. To all tubes (1 to 8) of each sets add one drop of the
respective TYDAL antigen suspension (O,AH, and BH) from the reagents
vials and mix well.
10. Cover the tubes and indicate incubate at 37°C overnight
(approximately 18 hours).
11. Dislodge the sedimented button gently and observe for agglutination.
INTERPRETATION OF RESULTS
SLIDE TEST METHOD
Agglutination is a positive test result and indicates presence of
clinically significant levels of the corresponding antibody in the
patient serum. No agglutination is a negative test result and indicates
the absence of clinically significant levels of the corresponding
antibody in the patient serum.
QUANTITATIVE METHOD
The titre of the patient serum using WIDAL antigen suspensions is
the highest dilution of the serum sample that gives a visible agglutination.
REMARKS
1. TAB vaccinated patients may show high titre of antibodies
to each of the antigens.
2. 'O' being a somatic antigen brings about coarse, compact,
granular agglutination whereas 'H' being a flagellar antigen brings
about larger, loose, flocculant agglutination.
3. 'H' antigen, being species specific, is more reliable in
determining the type of infection.
4. Turbid and contaminated sera should not be used for testing.
5. Generally antibody titres 1:80 or more are considered clinically
and diagnostically significant.
6. It is recommended that results of the tests should be correlated
with clinical findings to arrive at the final diagnosis.
7. since techniques and standardization vary from lab to lab
one tube difference in tube titres can be expected.
|